1 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8362).
|
2 |
ClinicalTrials.gov (NCT01620528) A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain. U.S. National Institutes of Health.
|
3 |
FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer. Clin Cancer Res. 2014 Sep 1;20(17):4436-41.
|
4 |
An FDA phase I clinical trial of quinacrine sterilization (QS). Int J Gynaecol Obstet. 2003 Oct;83 Suppl 2:S45-9.
|
5 |
Bishop-Freeman SC, Shonsey EM, Friederich LW, Beuhler MC, Winecker RE: Benzonatate Toxicity: Nothing to Cough At. J Anal Toxicol. 2017 Jun 1;41(5):461-463. doi: 10.1093/jat/bkx021.
|
6 |
Elagolix, a novel, orally bioavailable GnRH antagonist under investigation for the treatment of endometriosis-related pain. Womens Health (Lond Engl). 2015 Jan;11(1):19-28.
|
7 |
Use of cognitive behavior therapy for functional hypothalamic amenorrhea. Ann N Y Acad Sci. 2006 Dec;1092:114-29.
|
8 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
|
9 |
Age attenuates testosterone secretion driven by amplitude-varying pulses of recombinant human luteinizing hormone during acute gonadotrope inhibiti... J Clin Endocrinol Metab. 2007 Sep;92(9):3626-32.
|
10 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
|
11 |
Regulation of GnRH I receptor gene expression by the GnRH agonist triptorelin, estradiol, and progesterone in the gonadotroph-derived cell line alphaT3-1. Endocrine. 2006 Aug;30(1):139-44.
|
12 |
Clinical pipeline report, company report or official report of Takeda (2009).
|
13 |
Reversible downregulation of endocrine and germinative testicular function (hormonal castration) in the dog with the GnRH-agonist azagly-nafarelin ... Theriogenology. 2009 Apr 15;71(7):1037-45.
|
14 |
Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas. Prostate. 2009 Jul 1;69(10):1025-33.
|
15 |
2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
|
16 |
Iterative approach to the discovery of novel degarelix analogues: substitutions at positions 3, 7, and 8. Part II. J Med Chem. 2005 Jul 28;48(15):4851-60.
|
17 |
Cerner Multum, Inc. "Australian Product Information.".
|
18 |
Product Information. Orilissa (elagolix). AbbVie US LLC, North Chicago, IL.
|
19 |
Cerner Multum, Inc. "UK Summary of Product Characteristics.".
|
20 |
Product Information. Mycobutin (rifabutin). Pharmacia and Upjohn, Kalamazoo, MI.
|
21 |
Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
|
22 |
Product Information. Verzenio (abemaciclib). Lilly, Eli and Company, Indianapolis, IN.
|
23 |
Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
|
24 |
Product Information. Aliqopa (copanlisib). Bayer Pharmaceutical Inc, West Haven, CT.
|
25 |
Product Information. Tazverik (tazemetostat). Epizyme, Inc, Cambridge, MA.
|
26 |
Product Information. Pifeltro (doravirine). Merck & Company Inc, Whitehouse Station, NJ.
|
27 |
Ace LN, Jaffe JM, Kunka RL "Effect of food and an antacid on quinidine bioavailability." Biopharm Drug Dispos 4 (1983): 183-90. [PMID: 6882885]
|
28 |
Product Information. Diabinese (chlorpropamide). Pfizer US Pharmaceuticals, New York, NY.
|
29 |
Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
|
30 |
Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
|
31 |
Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
|
32 |
Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
|
33 |
EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
|
34 |
Product Information. Bevyxxa (betrixaban). Portola Pharmaceuticals, South San Francisco, CA.
|
|
|
|
|
|
|